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ABSTRACT
Objective: Review available literature on pelvic inflammatory disease in postmenopausal women.
Design: MEDLINE literature review from 1966 to 1999.
Results: Pelvic inflammatory disease is uncommon in postmenopausal women. It is polymicro-
bial, often is concurrent with tuboovarian abscess formation, and is often associated with other
diagnoses.
Conclusion: Postmenopausal women with pelvic inflammatory disease are best treated with in-
patient parenteral antimicrobials and appropriate imaging studies. Failure to respond to antibiotics
should yield a low threshold for surgery, and consideration of alternative diagnoses should be
entertained. Infect. Dis. Obstet. Gynecol. 7:248-252, 1999. (C) 1999Wiley-Liss, Inc.
KEY WORDS
menopause; tuboovarian abscess; diverticulitis
elvic inflammatory disease (PID) is a common
and serious complication of sexually transmit-
ted diseases in young women but is rarely diag-
nosed in the postmenopausal woman. The epide-
miology of PlD,.as well as the changes that occur in
the genital tract of postmenopausal women, ex-
plain this discrepancy. The exact incidence of PID
in postmenopausal women is unknown; however,
in one series, fewer than 2% of women with tubo-
ovarian abscess formation were postmenopausal.
Despite the rarity with which PID occurs in the
postmenopausal woman, consideration and early
recognition of the diagnosis along with appropriate
therapy can decrease the morbidity and mortality
associated with what is usually a serious infection.
PATHOPHYSIOLOGY
Pelvic inflammatory disease is an infection of the
upper genital tract most commonly seen in young
women. Typically, the risk factors associated with
PID are young age, low socioeconomic status, sub-
stance abuse, lack of barrier contraception, use of
an intrauterine device (IUD), and vaginal douch-
ing. z The pathophysiology involves the ascending
spread of pathogens initially found within the en-
docervix, with the most common etiologic agents
being the sexually transmitted microorganisms
Neisseria gonorrhoeae and Chlamydia trachomatis.
These bacteria are identified in 60-75% of pre-
menopausal women with PID.3 Other responsible
microorganisms include respiratory pathogens,
such as Haemophilus influenzae
4,s and Streptococcus
pyogenes,s and bacterial vaginosis-associated micro-
organisms (Prevotella, Peptostreptococcus).3,6
Cervical factors play a role in the development
of PID. The columnar epithelium of the endocer-
vix is commonly found everted in women of repro-
ductive age, and this is accentuated with use of oral
contraceptive pills. Both N. gonorrhoeae and C. tra-
chomatis attach preferentially to these columnar en-
docervical cells. With menopause, the cervical
transformation zone is anatomically located within
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the endocervical canal and is smaller than in pre-
menopausal women, decreasing the area of attach-
ment available to C. trachomatis and N. gonorrhoeae.
These changes most likely lower the susceptibility
of the postmenopausal woman to infection. The
endocervix also acts as a functional barrier to as-
cending infection. This barrier can be attenuated
by the changing rheologic properties of the cervical
mucus as noted during ovulation or breached by
the occurrence of retrograde menstruation. Physi-
ologically, the cervical mucus of the menopausal
woman is more tenacious and serves as a mechani-
cal barrier to ascending infections. Lack of men-
struation in menopausal women decreases the risk
of infection of the upper genital tract.
The direct extension of infectious processes
from adjacent intraabdominal viscera is more likely
to be associated with PID in older women. Disor-
ders such as diverticulitis, Crohn disease, colonic
cancers, and appendicitis have been associated
with a direct spread of infection to the ovaries, ovi-
ducts, and uterus and manifest as a unilateral or
bilateral tuboovarian abscess. 1,7,8 Fistula formation
from an abscess cavity to the genital tract has also
been described.9,1
RISK FACTORS
Older women are less likely to have risk factors
known to be associated with exposure to sexually
transmitted microorganisms. Behavioral, physi-
ologic, and anatomic alterations that occur with ad-
vancing age offer barriers to the usual means of
developing PID.
Sexual activity is a prerequisite for the develop-
ment of PID in younger women, and high coital
frequency has been associated with acquiring the
disease. The precise mechanism determining the
spread of microorganisms from the lower genital
tract to the upper genital tract is poorly understood;
however, this suggests a role of spermatozoa as a
vehicle for transporting the microorganisms to the
upper genital tract. Most older women have fewer
sexual partners and less frequent coital activity, lz
making them less likely to develop PID.
A risk factor associated with the development of
PID in the postmenopausal woman is uterine in-
strumentation. Such procedures may introduce mi-
croorganisms into the endometrial cavity, which
can lead to an infection of the upper genital tract.
One series reported that 45% of women with post-
menopausal PID had previous uterine instrumen-
tation, the majority within 2 weeks of the diagno-
sis. 13 Both a fractionated dilation and curettage ta
and office sampling with an aspirating pipette can
be associated with the development of PID. Ag-
gressive sampling may lead to uterine perforation,
which allows the direct inoculation of microorgan-
isms into the peritoneal cavity.
Structural abnormalities of the genital tract, such
as cervical stenosis, uterine anatomic abnormalities,
and tubal disease, are also associated with an in-
creased risk of developing PID.6 A history of cer-
vical conization, cryotherapy, or loop electrosurgi-
cal excision procedure can be associated with the
development of cervical stenosis. This, in addition
to other lesions, such as visible cervical malignan-
cies, submucous myomas, and endometrial polyps,
can block the efflux of blood or other fluids from
the uterine cavity. A collection of fluid within the
uterine cavity, such as blood (hematometra) or
clear fluid (hydrometra), can become contaminated
with microorganisms, causing a pyometra. This in-
fected fluid may then reflux into the fallopian
tubes and subsequently into the peritoneal cavity.
A prior history of PID with subsequent tubal
scarring or hydrosalpinx formation results in fallo-
pian tubes that are more susceptible to nonsexually
transmitted aerobic pathogens, such as H. influen-
zae, group B streptococcus, and Escherichia coli. 5
Chronic or recurring PID, however, appears to be
an uncommon cause of pelvic organ infection in the
older population. 14
The vaginal flora of postmenopausal women is
more likely to be populated with aerobic gram-
negative bacteria, especially E. coli, particularly if
they do not take estrogen replacement therapy.5 If
these potentially pathogenic bacteria gain entry
into the upper genital tract and a concomitant ab-
normality fails to allow the secretions of the upper
genital tract to be drained, an environment condu-
cive to suppurative infection can occur. Degenera-
tion of uterine myomas has been associated with
bacterial superinfection and infection of the genital
tract.6
Finally, a "forgotten" IUD may be associated
with a more serious genital tract infection. Landers
et al. revealed that up to one third of women with
tuboovarian abscess currently or were past users of
IUDs.6 In some cases, infections may be due to
Actinomyces israelii, a gram-positive anaerobic organ-
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ism. This infection occurs almost exclusively in
women who have an IUD in situ. 17 Characteristi-
cally, these patients have pelvic abscess formation
and may exhibit evidence of fistula development.
On pelvic exam, palpable indurated masses may be
present, suggesting a possible genital tract malig-
nancy.
MICROBIOLOGY
The postmenopausal woman diagnosed with PID
is less likely to harbor a sexually transmitted organ-
ism than the premenopausal woman. In most re-
ported cases, 1,7,18,19 the organisms most frequently
encountered were E. coli (76%) and Klebsiella
(43%). These microorganisms were also identified
in combination in 50-67% of bacteriologic cultures
obtained from the infected tissues. ,7,18 Other bac-
teria isolated include Pseudomonas (14%), Staphylo-
coccus aureus (<5%), Staphylococcus albus (<5%), and
enterococcus spp.,7,8-z Anaerobic organisms, such
as Bacteroides fragilis, were recovered in several
cases.8,3,19 Other aerobic pathogens, such as H.
influenzae and group B streptococcus, may cause an
ascending infection, and concomitant genital tract
pathology is likely to be detected.
CLINICAL MANIFESTATIONS
The most common presenting symptoms for post-
menopausal women with PID are vaginal spotting
or bleeding, abdominal pain, fever, nausea, and
change in bowel habits. 1,7,8,13,18 Isolated postmeno-
pausal bleeding is a warning of a potentially serious
problem and should prompt an investigation into
its source. Physical examination should begin with
evaluation of vaginal secretions for the presence of
inflammation in the lower genital tract. A wet
mount of vaginal secretions should reveal a pre-
dominance of inflammatory cells. Mucopurulent
endocervicitis may be present, with a green or yel-
low discharge arising from the endocervix. The cer-
vix may also be erythematous and friable (i.e.,
bleeds easily when touched with a cotton swab).
Tests for N. gonorrhoeae and C. trachomatis endo-
cervical infection should be obtained, and a bi-
manual examination should be performed to assess
the presence or absence of cervical motion tender-
ness, uterine tenderness, and adnexal tenderness.
Bimanual examination is likely to reveal the pres-
ence of a pelvic mass, pelvic tenderness, and, oc-
casionally, physical signs of peritoneal irritation.
Additional laboratory values that may aid in the
diagnosis include a complete blood count (specifi-
cally to identify a leukocytosis) and C-reactive pro-
tein. A Papanicolaou smear of the ecto- and endo-
cervix should be obtained if not recently per-
formed. Endometrial biopsy should be considered
and, if obtained, sent for pathologic and microbio-
logic evaluation. Computed tomography (CT) or
pelvic ultrasonography should be performed in
most postmenopausal women with PID, because
the majority will have evidence of a tuboovarian
abscess. 1,7,as-z0
In premenopausal patients, pelvic organ tender-
ness and either leukorrhea or mucopurulent endo-
cervicitis must be present to make the clinical di-
agnosis of PID. Because contiguous spread of in-
fection from diseased adjacent organs is a common
mechanism ofPID in older women, leukorrhea and
mucopurulent endocervicitis may not be present
on examination in these cases.
A review of the literature reveals that the ma-
jority of postmenopausal women with PID have an
associated tuboovarian abscess. ’7’8’1,8,a9 The di-
agnosis of this abscess is rarely made preoperatively
without appropriate imaging studies, and many
women develop morbid complications including
colocutaneous fistulas, wound infections, sepsis, re-
nal failure, pulmonary embolism, and death. Asso-
ciated findings at surgery include leiomyomas,
presence of an IUD, squamous cell carcinoma of
the cervix, adenocarcinoma of the endocervix, en-
dometrial polyps, hyperplasia, adenocarcinoma,
and epithelial ovarian carcinoma. Extragenital find-
ings are primarily bowel related, with diverticulitis,
appendicitis, inflammatory bowel disease, diver-
ticulosis, perforations of the gastrointestinal tract, and
colorectal carcinoma among those reported. 1,7,14,18-z
Several series reported that greater than 40% of
postmenopausal women with PID had an associ-
ated malignancy.’a4
DIFFERENTIAL DIAGNOSES
The most important differential diagnosis to con-
sider in postmenopausal women with PID is acute
diverticulitis with or without associated pelvic ab-
scess. Diverticulitis is the most common nonneo-
plastic gastrointestinal disorder associated with the
diagnosis of postmenopausal PID.el Women with
diverticulitis will commonly present with a pre-
dominance of bowel symptoms, as opposed to the
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patient with PID. In addition, women with diver-
ticulitis do not experience concurrent vaginal
bleeding. Diverticular disease affects 5-10% of the
population over 45 years old, and nearly 80% of
those over 85; however, only 20% become symp-
tomatic. The sigmoid and descending colon are the
most common sites of involvement. Computed to-
mography is considered the diagnostic modality of
choice for the evaluation of suspected diverticulitis
and allows for the exclusion of other intraabdomi-
nal and pelvic pathology, including abscess forma-
tion.zz
Appendicitis is an additional consideration in
the differential diagnosis of the postmenopausal
woman with PID, although it more commonly oc-
curs in the younger population. Diagnostic modali-
ties useful in the evaluation of appendicitis include
ultrasonography and CT. Transabdominal ultra-
sound examination of the right lower quadrant may
reveal a noncompressible tubular structure with
thickened muscular walls. Sensitivity and specific-
ity of ultrasound in the diagnosis of appendicitis is
reported as 76% and 91%, respectively, with a posi-
tive predictive value of 95%. Computed tomogra-
phy evaluation of acute appendicitis reveals a posi-
tive predictive value of 96%, with a sensitivity of
96% and specificity of 89%. Computed tomography
has also been shown to be more accurate in the
diagnosis of associated periappendiceal abscess, as
compared with ultrasound,z3
Laparoscopy has remained the gold standard for
the diagnosis of PID, because it provides direct
visualization of the pelvis, as well as other intraab-
dominal organs, to confirm the diagnosis and grade
the extent of disease. Liberal use of laparoscopy
should be considered in older women with uncer-
tain diagnoses following appropriate imaging stud-
ies, because they are more likely to have other in-
traabdominal pathology associated with the diagno-
sis of PID.
TREATMENT
Most postmenopausal women with PID will have
systemic signs of a severe infection and therefore
should be hospitalized. In situ IUDs should be re-
moved after parenteral antibiotics are instituted.
Several antimicrobial regimens can be recom-
mended for the treatment of PID in this age group.
Any regimen should possess excellent activity
against the common microorganisms associated
TABLE I. Suggested antimicrobial regimens for the
treatment of postmenopausal PIDa’b
Regimen A Regimen B
Clindamycin, 900 mg
intravenously every
8 hours,
plus
Gentamicin, intravenous
loading dose (2 mg/kg body
weight) followed by a
maintenance dose
(I.5 mg/kg) every 8 hours,
plus
Ampicillin, g intravenously
every 4 hours
Ofloxacin, 400 mg intravenously
every 12 hours,
plus
Clindamycin, 900 mg
intravenously every 8 hours
or
Metronidazole, 500 mg
intravenously every 8 hours
aModified from Centers for Disease Control and Prevention. 1998
Guidelines for treatment of sexually transmitted diseases. MMWR
Morb Mortal Wkly Rep 1998;47(RR-I):79-86.
bother options include the extended spectrum penicillins with beta
lactamase inhibitors (ticarcillin/clavulanate, ampicillin/sulbactam, and pi-
peracillin/tazobactam), extended spectrum cephalosporins (cefotetan
and cefoxitin), and the carbapenems (imipenem/cilastatin and mero-
penem).
with postmenopausal PID, namely, E. coli and
Klebsiella spp. In addition, because of the common
association of tuboovarian abscess formation, anti-
microbial coverage of anaerobic bacteria is manda-
tory. Box lists several regimens that are accept-
able for the treatment of postmenopausal PID.
These antimicrobial regimens possess a broad
spectrum of activity against aerobic and anaerobic
microorganisms and should penetrate abscess cavi-
ties well.
Early surgical intervention in the management
of postmenopausal women with PID should be en-
tertained after excluding the possibility of cervical
carcinoma. These patients commonly have severe
disease characterized by tuboovarian abscess for-
mation, and many have complicating medical ill-
nesses, such as diabetes and coronary heart disease.
As a group, they are less resilient than are younger
women with PID and are more likely to manifest
severe systemic signs of sepsis, including shock.
Mortality rates of 25% have been reported despite
adequate antimicrobial and surgical treatment, is
Moreover, the common association of inflammatory
bowel disease, other extragenital pathology, and
genital tract malignancies with PID in this age
group allows surgical exploration to be both diag-
nostic and therapeutic. Percutaneous drainage of
pelvic abscesses has become more common in the
treatment of tuboovarian abscess following failed
antimicrobial therapy; however, this treatment mo-
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dality has not been evaluated in postmenopausal
women with tuboovarian abscess.
SUMMARY
Pelvic inflammatory disease is a rare entity in post-
menopausal women. Extragenital pathology in ad-
dition to genital tract malignancies must be consid-
ered in these patients. The microbiology in post-
menopausal women is not typically associated with
the sexually transmitted disease microorganisms.
Tuboovarian abscess formation is common. Broad-
spectrum antimicrobial therapy should be initiated,
and appropriate imaging studies obtained. Serious
consideration of surgical exploration should be en-
tertained if the patient does not clinically improve
within 48 hours. Aggressive treatment of these se-
riously ill women may lead to a decrease in the
morbidity and mortality associated with this dis-
ease.
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